Search research articles
Contact Us
Filters
Showing results (111-120 of 251) with videos related to
Page
of 26
Sort By:
Archives of Otolaryngology (Chicago, Ill. : 1960)
|
February 1, 1981
Bell's palsy and herpes simplex virus
A Vahlne, S Edström, P Arstila, et al.
The American Journal of Medicine
|
July 1, 1994
Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients
H A Preti, S O'Brien, S Giralt, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1987
Sensitivity and resistance to chemotherapy in acute leukemia: correlation with in vitro drug uptake and lack of potentiation by verapamil
B S Andersson, M Beran, S E Stuckey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2000
The topoisomerase I inhibitor DX-8951f is active in a severe combined immunodeficient mouse model of human acute myelogenous leukemia
N Vey, F J Giles, H Kantarjian, et al.
Blood
|
August 12, 2000
Differences between refractory anemia with excess blasts in transformation and acute myeloid leukemia
M Albitar, M Beran, S O'Brien, et al.
Annals of Internal Medicine
|
February 15, 1995
Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service
H M Kantarjian, T L Smith, S O'Brien, et al.
Cancer
|
August 15, 1991
Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemia
S O'Brien, H Kantarjian, E Estey, et al.
Cancer Research
|
February 1, 1991
Phase I clinical investigation of benzisoquinolinedione (amonafide) in adults with refractory or relapsed acute leukemia
S O'Brien, J A Benvenuto, E Estey, et al.
Investigational New Drugs
|
November 11, 1999
Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: results of a randomized phase I/II study
N Vey, H Kantarjian, M Beran, et al.
Blood
|
December 1, 1995
Growth and biologic properties of karyotypically defined subcategories of adult acute lymphocytic leukemia in mice with severe combined immunodeficiency
S Jeha, H Kantarjian, S O'Brien, et al.
Page
of 26
Search research articles
Search
Showing results (111-120 of 251) with videos related to
Sort By:
Page
of 26
Archives of Otolaryngology (Chicago, Ill. : 1960)
|
February 1, 1981
Bell's palsy and herpes simplex virus
A Vahlne, S Edström, P Arstila, et al.
The American Journal of Medicine
|
July 1, 1994
Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients
H A Preti, S O'Brien, S Giralt, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1987
Sensitivity and resistance to chemotherapy in acute leukemia: correlation with in vitro drug uptake and lack of potentiation by verapamil
B S Andersson, M Beran, S E Stuckey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2000
The topoisomerase I inhibitor DX-8951f is active in a severe combined immunodeficient mouse model of human acute myelogenous leukemia
N Vey, F J Giles, H Kantarjian, et al.
Blood
|
August 12, 2000
Differences between refractory anemia with excess blasts in transformation and acute myeloid leukemia
M Albitar, M Beran, S O'Brien, et al.
Annals of Internal Medicine
|
February 15, 1995
Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service
H M Kantarjian, T L Smith, S O'Brien, et al.
Cancer
|
August 15, 1991
Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemia
S O'Brien, H Kantarjian, E Estey, et al.
Cancer Research
|
February 1, 1991
Phase I clinical investigation of benzisoquinolinedione (amonafide) in adults with refractory or relapsed acute leukemia
S O'Brien, J A Benvenuto, E Estey, et al.
Investigational New Drugs
|
November 11, 1999
Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: results of a randomized phase I/II study
N Vey, H Kantarjian, M Beran, et al.
Blood
|
December 1, 1995
Growth and biologic properties of karyotypically defined subcategories of adult acute lymphocytic leukemia in mice with severe combined immunodeficiency
S Jeha, H Kantarjian, S O'Brien, et al.
Page
of 26